Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interactions of Simeprevir and Ledipasvir in HCV
NCT02421211Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of simeprevir in hepatitis C virus infection, sponsored by Janssen Pharmaceutical. Started May 2015; status: completed.
02
Drugs
simeprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02421211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421211.